Exclusive | Cipla, Dr Reddy#39;s, Carlyle and Hong Kong fund in fray for Wockhardt divisions
Wockhardt has a diversified product portfolio with presence in therapeutic segments such as cardiology, dermatology, diabetes, respiratory and ophthalmology. It is not clear which of these divisions will be sold.
Latest News from Moneycontrol.com